BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18394045)

  • 1. Creutzfeldt-Jakob disease: hopes for therapy.
    Pocchiari M; Ladogana A; Graziano S; Puopolo M
    Eur J Neurol; 2008 May; 15(5):435-6. PubMed ID: 18394045
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental treatment may show promise for vCJD.
    Pincock S
    Lancet; 2003 Oct; 362(9390):1130. PubMed ID: 14558510
    [No Abstract]   [Full Text] [Related]  

  • 3. [Creutzfeldt-Jakob disease].
    Tanii H; Takeda M
    Ryoikibetsu Shokogun Shirizu; 2003; (40):319-23. PubMed ID: 14626130
    [No Abstract]   [Full Text] [Related]  

  • 4. [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
    Stølsmark T; Tysnes OB
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):601-4. PubMed ID: 20349004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicines committee felt unable to recommend use of pentosan polyphosphate in vCJD.
    Gould M
    BMJ; 2003 Oct; 327(7418):770. PubMed ID: 14525869
    [No Abstract]   [Full Text] [Related]  

  • 6. Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease.
    Whittle IR; Knight RS; Will RG
    Acta Neurochir (Wien); 2006 Jun; 148(6):677-9; discussion 679. PubMed ID: 16598408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?
    Rainov NG; Tsuboi Y; Krolak-Salmon P; Vighetto A; Doh-Ura K
    Expert Opin Biol Ther; 2007 May; 7(5):713-26. PubMed ID: 17477808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate.
    Terada T; Tsuboi Y; Obi T; Doh-ura K; Murayama S; Kitamoto T; Yamada T; Mizoguchi K
    Acta Neurol Scand; 2010 Feb; 121(2):127-30. PubMed ID: 19804470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.
    Newman PK; Todd NV; Scoones D; Mead S; Knight RS; Will RG; Ironside JW
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):921-4. PubMed ID: 24554103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second vCJD patient to receive experimental treatment.
    Dyer C
    BMJ; 2003 Oct; 327(7420):886. PubMed ID: 14563724
    [No Abstract]   [Full Text] [Related]  

  • 11. Small improvement seen in teenager with vCJD.
    Mayor S
    BMJ; 2003 Oct; 327(7418):765. PubMed ID: 14525852
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
    Parry A; Baker I; Stacey R; Wimalaratna S
    J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):733-4. PubMed ID: 17314188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
    Todd NV; Morrow J; Doh-ura K; Dealler S; O'Hare S; Farling P; Duddy M; Rainov NG
    J Infect; 2005 Jun; 50(5):394-6. PubMed ID: 15907546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies.
    Farquhar C; Dickinson A; Bruce M
    Lancet; 1999 Jan; 353(9147):117. PubMed ID: 10023899
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentosan for interstitial cystitis.
    Med Lett Drugs Ther; 1997 Jun; 39(1002):56. PubMed ID: 9198728
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulphate.
    Toren PJ; Norman RW
    J Urol; 2005 Jan; 173(1):103. PubMed ID: 15592042
    [No Abstract]   [Full Text] [Related]  

  • 17. Family finds hospital willing to give experimental CJD treatment.
    Dyer O
    BMJ; 2003 Jan; 326(7379):8. PubMed ID: 12511437
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
    Bone I; Belton L; Walker AS; Darbyshire J
    Eur J Neurol; 2008 May; 15(5):458-64. PubMed ID: 18355301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from Therapeutic Studies for PrP Prion Disease.
    Teruya K; Doh-Ura K
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 27836910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial cystitis.
    Myers DL
    Med Health R I; 2009 Jan; 92(1):22-6. PubMed ID: 19248422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.